The California nonprofit Center for Judicial Excellence report finds family courts often miss signs of trouble and put children in harm’s way.
Author: Ken Alltucker, USA TODAY
Esai and Biogen, Leqembi manufacturer, receive FDA approval for Alzheimer’s drug
Eisai and Biogen’s drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA’s full review.
Fourth of July fireworks come as some parts of US are ‘primed to burn’
Experts warn hot, dry conditions are ripe for wildfires ahead of Fourth of July celebrations. Some cities turn to drone light displays to curb risk.
When will lecanemab be available? Eisai and Biogen Alzheimer’s drug awaits FDA approval
The FDA must decide by July 6 whether to approve Leqembi, the first amyloid-busting drug up for full approval. Advocates and scientists are watching.
Here’s why most at-risk populations don’t use HIV prevention drugs
Even with a newer, longer-acting injectable version available, the HIV prevention medication known as PrEP does not reach most who can benefit.
Drugmaker Merck sues the Biden administration over Medicare’s drug price negotiations
Merck said the price negotiations are a ‘sham’ that compel drugmakers to accept lower prices, according to a lawsuit.
FDA seeks to ease cancer drug shortage with China-made imports
More than one dozen cancer drugs have been in shortage in recent months, including cisplatin and carboplatin. U.S. eases import restrictions.
FDA warns about herbal drug kratom, used for pain relief: What to know about side effects
The FDA recently seized a large shipment of kratom. Here’s what to know about the herbal drug and how it’s used to treat pain and anxiety.
Artificial intelligence helps researchers find new antibiotic to fight deadly superbug
Researchers report they used an AI algorithm to predict molecules that would neutralize the drug-resistant bacteria Acinetobacter baumannii.
Doctors and patients are worried this large health insurer’s new policy will delay care
Doctors are raising concerns about UnitedHealthcare’s policy to require authorization before some colonoscopies and cancer scopes.